Sfoglia per Autore
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes
2024 Ciardullo, S; Morieri, M; Daniele, G; Fiorentino, T; Mezza, T; Tricò, D; Consoli, A; Del Prato, S; Giorgino, F; Piro, S; Solini, A; Avogaro, A
The MAFLD‐MASLD debate: Does cardiovascular risk prediction define the winner?
2024 Ciardullo, S
Steatotic Liver Disease Phenotypes in the United States: The Impact of Alcohol Consumption Assessment
2024 Ciardullo, S; Perseghin, G
Development of a new model of insulin sensitivity in patients with type 2 diabetes and association with mortality
2024 Ciardullo, S; Dodesini, A; Lepore, G; Corsi, A; Scaranna, C; Perseghin, G; Trevisan, R
Resmetirom for the treatment of nonalcoholic steatohepatitis: Evaluating the robustness of available evidence
2024 Ciardullo, S; Mantovani, A
Time trends in liver-related mortality in people with and without diabetes: Results from a population based study
2024 Ciardullo, S; Morabito, G; Rea, F; Savaré, L; Perseghin, G; Corrao, G
NAIF: A novel artificial intelligence-based tool for accurate diagnosis of stage F3/F4 liver fibrosis in the general adult population, validated with three external datasets
2024 Hassoun, S; Bruckmann, C; Ciardullo, S; Perseghin, G; Marra, F; Curto, A; Arena, U; Broccolo, F; Di Gaudio, F
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes
2024 Trevisan, R; Conti, M; Ciardullo, S
Advancements in pharmacological treatment of NAFLD/MASLD: a focus on metabolic and liver-targeted interventions
2024 Ciardullo, S; Muraca, E; Vergani, M; Invernizzi, P; Perseghin, G
Reliability of heart rate in reflecting cardiac sympathetic overdrive in type 2 diabetes mellitus
2024 Dell'Oro, R; Quarti-Trevano, F; Ciardullo, S; Perseghin, G; Mancia, G; Grassi, G
Adherence to GLP1-RA and SGLT2-I affects clinical outcomes and costs in patients with type 2 diabetes
2024 Ciardullo, S; Savaré, L; Rea, F; Perseghin, G; Corrao, G
Impact of MASLD and MetALD on clinical outcomes: A meta-analysis of preliminary evidence
2024 Ciardullo, S; Mantovani, A; Morieri, M; Muraca, E; Invernizzi, P; Perseghin, G
Liver stiffness is associated with all-cause mortality in patients with NAFLD: A systematic review and meta-analysis
2023 Ciardullo, S; Muraca, E; Zerbini, F; Perseghin, G
Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment
2023 Ciardullo, S; Vergani, M; Perseghin, G
Differential Association of Sex Hormones with Metabolic Parameters and Body Composition in Men and Women from the United States
2023 Ciardullo, S; Zerbini, F; Cannistraci, R; Muraca, E; Perra, S; Oltolini, A; Perseghin, G
Endocrinology and Metabolic Diseases (Including Diabetes)
2023 Cristoferi, L; Ciardullo, S; Invernizzi, P; Perseghin, G; Carbone, M
Trends in prevalence of probable fibrotic nonalcoholic steatohepatitis in the United States, 1999-2016
2023 Ciardullo, S; Perseghin, G
Low 25 (OH) vitamin D levels are associated with increased prevalence of NAFLD and significant liver fibrosis
2023 Ciardullo, S; Muraca, E; Cannistraci, R; Perra, S; Lattuada, G; Perseghin, G
Control of Blood Glucose and Cardiovascular Risk Profile
2023 Ciardullo, S; Perseghin, G
Silent threats: how NAFLD and hypertension team up in young adults, and the role of sex
2023 Ciardullo, S
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile